Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Nuclear Medicine

Free Subscription Articles published in Neurology Retrieve available abstracts of 62 articles: HTML format

Single Articles

June 2025
1. DUBBELMAN MA, Liu A, Donohue MC, Langford O, et al
   Changes in Daily Functioning in Association With Tau and Amyloid Among Unimpaired Older Adults With and Without Elevated Amyloid.
   Neurology. 2025;104:e213775.
   PubMed     Abstract available
   
   
   
2. GONZALEZ-ORTIZ F, Kirsebom BE, Yakoub Y, Gundersen JK, et al
   Associations Between Changes in Levels of Phosphorylated Tau and Severity of Cognitive Impairment in Early Alzheimer Disease.
   Neurology. 2025;104:e213676.
   PubMed     Abstract available
   
   
   
3. MENDES AJ, Ribaldi F, Pievani M, Boccalini C, et al
   Validating the Amyloid Cascade Through the Revised Criteria of Alzheimer's Association Workgroup 2024 for Alzheimer Disease.
   Neurology. 2025;104:e213675.
   PubMed     Abstract available
   
   
   May 2025
4. MUJANOVIC A, Yogendrakumar V, Ng FC, Gattringer T, et al
   Effect of Thrombolytics on Delayed Reperfusion After Incomplete Thrombectomy: Target Trial Emulation.
   Neurology. 2025;104:e213641.
   PubMed     Abstract available
   
   
   
5. OURRY V, Fajardo-Valdez A, Soucy JP, Poirier J, et al
   Amyloid and Tau Pathology in Cognitively Unimpaired Individuals With a Parental History of Alzheimer Disease: Role of Sex and Parent's Sex.
   Neurology. 2025;104:e213507.
   PubMed     Abstract available
   
   
   April 2025
6. BONOMI CG, Martorana A, Motta C, Serafini C, et al
   Autonomic Dysfunction in Patients With Dementia With Lewy Bodies and Its Relationship With Nigrostriatal Denervation.
   Neurology. 2025;104:e213463.
   PubMed     Abstract available
   
   
   
7. DEMEESTERE J, Verhaaren BFJ, Christensen S, Wouters A, et al
   Underestimation of Follow-Up Infarct Volume by Acute CT Perfusion Imaging.
   Neurology. 2025;104:e213439.
   PubMed     Abstract available
   
   
   March 2025
8. TURPIN AL, Felisatti F, Chauveau L, Haudry S, et al
   Association Between Lifestyle at Different Life Periods and Brain Integrity in Older Adults.
   Neurology. 2025;104:e213347.
   PubMed     Abstract available
   
   
   
9. LI XY, Tang G, Lu J, Zhao Y, et al
   Self-Reported REM Sleep Behavior Disorder in Patients With Progressive Supranuclear Palsy: Clinical and (18)F-Florzolotau PET Imaging Findings.
   Neurology. 2025;104:e213376.
   PubMed     Abstract available
   
   
   
10. PALERMO G, Francesconi A, Bellini G, Morganti R, et al
    Involvement of the Nigrostriatal Pathway in Patients With Idiopathic Normal Pressure Hydrocephalus and Parkinsonism.
    Neurology. 2025;104:e213352.
    PubMed     Abstract available
    
    
    February 2025
11. LIANG J, Hussainy S, Lee SM, Wu G, et al
    Association of Polygenic Risk Score for 5 Diseases With Alzheimer Disease Progression, Biomarkers, and Amyloid Deposition.
    Neurology. 2025;104:e210250.
    PubMed     Abstract available
    
    
    
12. BORNHORST JA, Lundgreen CS, Weigand SD, Figdore DJ, et al
    Quantitative Assessment of the Effect of Chronic Kidney Disease on Plasma P-Tau217 Concentrations.
    Neurology. 2025;104:e210287.
    PubMed     Abstract available
    
    
    
13. JOUTSA J, Rinne JO, Niemi KJ, Karrasch M, et al
    Progression of Amyloid Accumulation in Late Adulthood Among People With Childhood-Onset Epilepsy.
    Neurology. 2025;104:e210303.
    PubMed     Abstract available
    
    
    
14. GARCIA-ESPERON C, Berry-Noronha A, Di Bartolo A, Green DS, et al
    Arterial Input Function Dispersal on Acute Brain CT Perfusion Scan in Patients With Acute Stroke and an Intracardiac Thrombus.
    Neurology. 2025;104:e210256.
    PubMed     Abstract available
    
    
    January 2025
15. QUISPIALAYA KM, Therriault J, Aliaga A, Benedet AL, et al
    Comparison of Plasma p-tau217 and [(18)F]FDG-PET for Identifying Alzheimer Disease in People With Early-Onset or Atypical Dementia.
    Neurology. 2025;104:e210211.
    PubMed     Abstract available
    
    
    
16. RODRIGUEZ-BAZ I, Benejam B, Morcillo-Nieto AO, Vaque-Alcazar L, et al
    Posterior Cortical Atrophy Due to Alzheimer Disease in a Person With Down Syndrome: A Case Report.
    Neurology. 2025;104:e210179.
    PubMed     Abstract available
    
    
    
17. CHEN Z, Jiang D, Kong Y, Zhang J, et al
    Association of Glymphatic Function With Clinical Characteristics in Patients With Clinical and Asymptomatic Creutzfeldt-Jakob Disease.
    Neurology. 2025;104:e210055.
    PubMed     Abstract available
    
    
    December 2024
18. YOO HS, Lee YG, Sohn YH, Yun M, et al
    Association of Relative Brain Hyperperfusion Independent of Dopamine Depletion With Motor Dysfunction in Patients With Parkinson Disease.
    Neurology. 2024;103:e210077.
    PubMed     Abstract available
    
    
    
19. YOO HS, Kim HK, Na HK, Kang S, et al
    Association of Striatal Dopamine Depletion and Brain Metabolism Changes With Motor and Cognitive Deficits in Patients With Parkinson Disease.
    Neurology. 2024;103:e210105.
    PubMed     Abstract available
    
    
    
20. BOCCALINI C, Dodich A, Scheffler M, Lagana V, et al
    In Vivo Tau and Neurodegeneration Imaging in a Family With the Presenilin 1 Met146Leu Pathogenic Variant.
    Neurology. 2024;103:e210103.
    PubMed     Abstract available
    
    
    
21. BISCHOF GN, Jaeger E, Giehl K, Jessen F, et al
    Cortical Tau Aggregation Patterns Associated With Apraxia in Patients With Alzheimer Disease.
    Neurology. 2024;103:e210062.
    PubMed     Abstract available
    
    
    
22. VELLIEUX G, Apartis E, Baudin P, Del Rio Quinones MA, et al
    Multimodal Assessment of the Origin of Myoclonus in Lance-Adams Syndrome.
    Neurology. 2024;103:e209994.
    PubMed     Abstract available
    
    
    November 2024
23. PENSATO U, Bosshart S, Stebner A, Rohr A, et al
    Effect of Hemoglobin and Blood Glucose Levels on CT Perfusion Ischemic Core Estimation: A Post Hoc Analysis of the ESCAPE-NA1 Trial.
    Neurology. 2024;103:e209939.
    PubMed     Abstract available
    
    
    
24. MICHAELSON NM, Klawiter EC, Singhal T
    Journal Club: PET Imaging in Multiple Sclerosis and Its Prognostic Implications.
    Neurology. 2024;103:e210047.
    PubMed    
    
    
    
25. LAM AD, Thibault EG, Mayblyum DV, Hsieh S, et al
    Association of Seizure Foci and Location of Tau and Amyloid Deposition and Brain Atrophy in Patients With Alzheimer Disease and Seizures.
    Neurology. 2024;103:e209920.
    PubMed     Abstract available
    
    
    
26. HAZAN J, Liu KY, Costello H, Isaacs JD, et al
    Challenges in a Biological Definition of Alzheimer Disease.
    Neurology. 2024;103:e209884.
    PubMed     Abstract available
    
    
    
27. WATANABE H, Duffy JR, Clark H, Machulda MM, et al
    Primary Progressive Aphasia Lacking Core Features of Nonfluent and Semantic Variants: Clinical, Neuroimaging, and Neuropathologic Features.
    Neurology. 2024;103:e209924.
    PubMed     Abstract available
    
    
    August 2024
28. ROMOLI M, Marinoni G, Tagliabue L, Capozza A, et al
    (18F)Flutemetamol-PET Aided Classification of Cerebral Amyloid Angiopathy: A Multicenter Study.
    Neurology. 2024;103:e209719.
    PubMed     Abstract available
    
    
    
29. VAN DER VEERE PJ, Hoogland J, Visser LNC, Van Harten AC, et al
    Predicting Cognitive Decline in Amyloid-Positive Patients With Mild Cognitive Impairment or Mild Dementia.
    Neurology. 2024;103:e209605.
    PubMed     Abstract available
    
    
    
30. NISHIDA A, Shima A, Kambe D, Furukawa K, et al
    Frontoparietal-Striatal Network and Nucleus Basalis Modulation in Patients With Parkinson Disease and Gait Disturbance.
    Neurology. 2024;103:e209606.
    PubMed     Abstract available
    
    
    
31. WANG J, Ackley S, Woodworth DC, Sajjadi SA, et al
    Associations of Amyloid Burden, White Matter Hyperintensities, and Hippocampal Volume With Cognitive Trajectories in the 90+ Study.
    Neurology. 2024;103:e209665.
    PubMed     Abstract available
    
    
    July 2024
32. MUJANOVIC A, Ng FC, Branca M, Deutschmann HA, et al
    External Validation of a Model for Persistent Perfusion Deficit in Patients With Incomplete Reperfusion After Thrombectomy: EXTEND-PROCEED.
    Neurology. 2024;103:e209401.
    PubMed     Abstract available
    
    
    
33. OH Y, Kim JS, Lyoo CH, Park G, et al
    Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson Disease-Related Cognitive Impairment.
    Neurology. 2024;103:e209498.
    PubMed     Abstract available
    
    
    
34. XIA Y, Dore V, Fripp J, Bourgeat P, et al
    Association of Basal Forebrain Atrophy With Cognitive Decline in Early Alzheimer Disease.
    Neurology. 2024;103:e209626.
    PubMed     Abstract available
    
    
    
35. MASTENBROEK SE, Sala A, Vallez Garcia D, Shekari M, et al
    Continuous beta-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity.
    Neurology. 2024;103:e209419.
    PubMed     Abstract available
    
    
    June 2024
36. BABULAL GM, Chen L, Murphy SA, Carr DB, et al
    Predicting Driving Cessation Among Cognitively Normal Older Drivers: The Role of Alzheimer Disease Biomarkers and Clinical Assessments.
    Neurology. 2024;102:e209426.
    PubMed     Abstract available
    
    
    
37. YE R, Goodheart AE, Locascio JJ, Peterec E, et al
    Differential Vulnerability of Hippocampal Subfields to Amyloid and Tau Deposition in the Lewy Body Diseases.
    Neurology. 2024;102:e209460.
    PubMed     Abstract available
    
    
    
38. JADICK MF, Robinson T, Farrell ME, Klinger H, et al
    Associations Between Self and Study Partner Report of Cognitive Decline With Regional Tau in a Multicohort Study.
    Neurology. 2024;102:e209447.
    PubMed     Abstract available
    
    
    
39. DI LUCA DG, Perlmutter JS
    Time for Clinical Dopamine Transporter Scans in Parkinsonism?: Not DAT Yet.
    Neurology. 2024;102:e209558.
    PubMed    
    
    
    
40. HASTINGS A, Cullinane P, Wrigley S, Revesz T, et al
    Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism.
    Neurology. 2024;102:e209453.
    PubMed     Abstract available
    
    
    May 2024
41. RUS T, Cuderman A, Georgiev D
    Parkinsonism Associated With Traumatic Hemorrhage in Substantia Nigra: Role of Presynaptic Dopaminergic Imaging.
    Neurology. 2024;102:e209384.
    PubMed    
    
    
    
42. COURTNEY MR, Antonic-Baker A, Chen Z, Sinclair B, et al
    Association of Localizing (18)F-FDG-PET Hypometabolism and Outcome Following Epilepsy Surgery: Systematic Review and Meta-Analysis.
    Neurology. 2024;102:e209304.
    PubMed     Abstract available
    
    
    
43. BARATEAU L, Krache A, Da Costa A, Lecendreux M, et al
    Microglia Density and Its Association With Disease Duration, Severity, and Orexin Levels in Patients With Narcolepsy Type 1.
    Neurology. 2024;102:e209326.
    PubMed     Abstract available
    
    
    April 2024
44. WEINSTEIN G, Kojis DJ, Ghosh S, Beiser AS, et al
    Association of Neurotrophic Factors at Midlife With In Vivo Measures of beta-Amyloid and Tau Burden 15 Years Later in Dementia-Free Adults.
    Neurology. 2024;102:e209198.
    PubMed     Abstract available
    
    
    
45. CAI Y, Shi D, Lan G, Chen L, et al
    Association of beta-Amyloid, Microglial Activation, Cortical Thickness, and Metabolism in Older Adults Without Dementia.
    Neurology. 2024;102:e209205.
    PubMed     Abstract available
    
    
    
46. GREENBERG S, Battioui C, Lu M, Biffi A, et al
    ARIA Insights from the Donanemab Trials (P1-9.001).
    Neurology. 2024;102.
    PubMed     Abstract available
    
    
    
47. APPLETON J, Funk Q, Fregonara PZ, Yu M, et al
    Neuroinflammation Co-localizes Highly with Tau in Mild Cognitive Impairment from Early Onset Alzheimer's Disease (N4.002).
    Neurology. 2024;102.
    PubMed     Abstract available
    
    
    March 2024
48. HONIG M, Altomare D, Caprioglio C, Collij L, et al
    Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease.
    Neurology. 2024;102:e208053.
    PubMed     Abstract available
    
    
    
49. ACKLEY S, Calmasini C, Bouteloup V, Hill-Jarrett TG, et al
    Contribution of Global Amyloid-PET Imaging for Predicting Future Cognition in the MEMENTO Cohort.
    Neurology. 2024;102:e208054.
    PubMed     Abstract available
    
    
    February 2024
50. RAHAYEL S, Postuma R, Baril AA, Misic B, et al
    (99m)Tc-HMPAO SPECT Perfusion Signatures Associated With Clinical Progression in Patients With Isolated REM Sleep Behavior Disorder.
    Neurology. 2024;102:e208015.
    PubMed     Abstract available
    
    
    January 2024
51. PALLEIS C, Franzmeier N, Weidinger E, Bernhardt AM, et al
    Association of Neurofilament Light Chain, [(18)F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With beta-Amyloid-Negative CBS.
    Neurology. 2024;102:e207901.
    PubMed     Abstract available
    
    
    December 2023
52. HANSEEUW BJ, Jacobs HIL, Schultz AP, Buckley RF, et al
    Association of Pathologic and Volumetric Biomarker Changes With Cognitive Decline in Clinically Normal Adults.
    Neurology. 2023;101:e2533-e2544.
    PubMed     Abstract available
    
    
    November 2023
53. YOON SH, Kim HK, Lee JH, Chun JH, et al
    Association of Sleep Disturbances With Brain Amyloid and Tau Burden, Cortical Atrophy, and Cognitive Dysfunction Across the AD Continuum.
    Neurology. 2023;101:e2162-e2171.
    PubMed     Abstract available
    
    
    October 2023
54. THEIS H, Bischof GN, Bruggemann N, Dargvainiene J, et al
    In Vivo Measurement of Tau Depositions in Anti-IgLON5 Disease Using (18)F-PI-2620 PET.
    Neurology. 2023 Oct 25:10.1212/WNL.0000000000207870.
    PubMed     Abstract available
    
    
    
55. BEAUCHAMP LC, Dore V, Villemagne VL, Xu S, et al
    Utilizing (18)F-AV-133 VMAT2 PET Imaging to Monitor Progressive Nigrostriatal Degeneration in Parkinson Disease.
    Neurology. 2023 Oct 10:10.1212/WNL.0000000000207748.
    PubMed     Abstract available
    
    
    September 2023
56. COOMANS EM, de Koning LA, Rikken RM, Verfaillie SC, et al
    Performance of a [(18)F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy Bodies.
    Neurology. 2023 Sep 25:10.1212/WNL.0000000000207794.
    PubMed     Abstract available
    
    
    
57. CHEVAL M, Rodrigo S, Leroy C, Taussig D, et al
    [(18)F]DPA-714 PET Imaging in the Presurgical Evaluation of Patients With Drug-Resistant Focal Epilepsy.
    Neurology. 2023 Sep 25:10.1212/WNL.0000000000207811.
    PubMed     Abstract available
    
    
    
58. MALPETTI M, Rabinovici GD
    From Clinical Trials to Memory Clinics, tau-PET Visual Reads Can Help Diagnosis and Patient Stratification.
    Neurology. 2023 Sep 25:10.1212/WNL.0000000000207935.
    PubMed    
    
    
    July 2023
59. DURCAN R, Roberts G, Hamilton CA, Donaghy PC, et al
    Serial Nigrostriatal Dopaminergic Imaging in Mild Cognitive Impairment With Lewy Bodies, Alzheimer Disease, and Age-Matched Controls.
    Neurology. 2023 Jul 31:10.1212/WNL.0000000000207621.
    PubMed     Abstract available
    
    
    
60. PROKOPIOU PC, Engels-Dominguez N, Schultz AP, Sepulcre J, et al
    Association of Novelty-Related Locus Coeruleus Function With Entorhinal Tau Deposition and Memory Decline in Preclinical Alzheimer Disease.
    Neurology. 2023 Jul 25:10.1212/WNL.0000000000207646.
    PubMed     Abstract available
    
    
    October 2022
61. CHUNG SJ, Kim YJ, Kim YJ, Lee HS, et al
    Association Between White Matter Networks and the Pattern of Striatal Dopamine Depletion in Patients With Parkinson Disease.
    Neurology. 2022 Oct 4. pii: WNL.0000000000201269.
    PubMed     Abstract available
    
    
    September 2022
62. KAMAGATA K, Andica C, Takabayashi K, Saito Y, et al
    Association of MRI Indices of Glymphatic System With Amyloid Deposition and Cognition in Mild Cognitive Impairment and Alzheimer Disease.
    Neurology. 2022 Sep 19. pii: WNL.0000000000201300.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge.